Nanotechnology oers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suer low therapeutic ecacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, dierent modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic ecacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of dierent cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.

Biomimetic Nanocarriers for Cancer Target Therapy

Maiorano G;Cortese B;D'Amone S;
2020

Abstract

Nanotechnology oers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suer low therapeutic ecacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, dierent modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic ecacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of dierent cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.
2020
Istituto di Nanotecnologia - NANOTEC
biomimetic nanoparticles; cancer therapy; immunotherapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/424316
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? ND
social impact